Literature DB >> 21460262

Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane.

Ilene K Sugino1, Qian Sun, Jianqiu Wang, Celia F Nunes, Noounanong Cheewatrakoolpong, Aprille Rapista, Adam C Johnson, Christopher Malcuit, Irina Klimanskaya, Robert Lanza, Marco A Zarbin.   

Abstract

PURPOSE: To compare RPE derived from human embryonic stem cells (hES-RPE) and fetal RPE (fRPE) behavior on human Bruch's membrane (BM) from aged and AMD donors.
METHODS: hES-RPE of 3 degrees of pigmentation and fRPE were cultured on BM explants. Explants were assessed by light, confocal, and scanning electron microscopy. Integrin mRNA levels were determined by real-time polymerase chain reaction studies. Secreted proteins in media were analyzed by multiplex protein analysis after 48-hour exposure at culture day 21.
RESULTS: hES-RPE showed impaired initial attachment compared to fRPE; pigmented hES-RPE showed nuclear densities similar to fRPE at day 21. At days 3 and 7, hES-RPE resurfaced BM to a limited degree, showed little proliferation (Ki-67), and partial retention of RPE markers (MITF, cytokeratin, and CRALBP). TUNEL-positive nuclei were abundant at day 3. fRPE exhibited substantial BM resurfacing at day 3 with decreased resurfacing at later times. Most fRPE retained RPE markers. Ki-67-positive nuclei decreased with time in culture. TUNEL staining was variable. Increased integrin mRNA expression did not appear to affect cell survival at day 21. hES-RPE and fRPE protein secretion was similar on equatorial BM except for higher levels of nerve growth factor and thrombospondin-2 (TSP2) by hES-RPE. On submacular BM, fRPE secreted more vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor, and platelet-derived growth factor; hES-RPE secreted more TSP2.
CONCLUSIONS: Although pigmented hES-RPE and fRPE resurfaced aged and AMD BM to a similar, limited degree at day 21, cell behavior at earlier times was markedly dissimilar. Differences in protein secretion may indicate that hES-RPE may not function identically to native RPE after seeding on aged or AMD BM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460262      PMCID: PMC3176062          DOI: 10.1167/iovs.10-5386

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  62 in total

Review 1.  Derive and conquer: sourcing and differentiating stem cells for therapeutic applications.

Authors:  Irina Klimanskaya; Nadia Rosenthal; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

2.  An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris.

Authors:  Magali Saint-Geniez; Tomoki Kurihara; Eiichi Sekiyama; Angel E Maldonado; Patricia A D'Amore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

3.  Propagation of fetal human RPE cells: preservation of original culture morphology after serial passage.

Authors:  M K Song; G M Lui
Journal:  J Cell Physiol       Date:  1990-04       Impact factor: 6.384

4.  Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.

Authors:  M Streit; L Riccardi; P Velasco; L F Brown; T Hawighorst; P Bornstein; M Detmar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Effects of the neurotrophin brain-derived neurotrophic factor in an experimental model of retinal detachment.

Authors:  G P Lewis; K A Linberg; S F Geller; C J Guérin; S K Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-06       Impact factor: 4.799

6.  Ca++-switch induction of RPE differentiation.

Authors:  Daniel J Rak; Katherine M Hardy; Glenn J Jaffe; Brian S McKay
Journal:  Exp Eye Res       Date:  2005-11-11       Impact factor: 3.467

7.  Human embryonic stem cell lines derived from single blastomeres.

Authors:  Irina Klimanskaya; Young Chung; Sandy Becker; Shi-Jiang Lu; Robert Lanza
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

8.  Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation.

Authors:  Tongalp H Tezel; Lucian V Del Priore; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

9.  Effects of nerve growth factor for retinal cell survival in experimental retinal detachment.

Authors:  Xiaodong Sun; Xun Xu; Fenghua Wang; Xi Zhang; Zhang Yu; Hongfen Lu; P C Ho
Journal:  Curr Eye Res       Date:  2007-09       Impact factor: 2.424

10.  Localizations of visual cycle components in retinal pigment epithelium.

Authors:  Jing Huang; Daniel E Possin; John C Saari
Journal:  Mol Vis       Date:  2009-01-26       Impact factor: 2.367

View more
  25 in total

Review 1.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

Review 2.  Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic.

Authors:  Paul Whiting; Julie Kerby; Peter Coffey; Lyndon da Cruz; Ruth McKernan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

3.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

Review 4.  Surgical approaches to gene and stem cell therapy for retinal disease.

Authors:  J Timothy Stout; Peter J Francis
Journal:  Hum Gene Ther       Date:  2011-05       Impact factor: 5.695

5.  Chapter 4 - Restoring Vision to the Blind: Stem Cells and Transplantation.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

Review 6.  Mechanisms for countering oxidative stress and damage in retinal pigment epithelium.

Authors:  Scott M Plafker; Gary B O'Mealey; Luke I Szweda
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 7.  Nanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases.

Authors:  Nathan A Hotaling; Vladimir Khristov; Qin Wan; Ruchi Sharma; Balendu Shekhar Jha; Mostafa Lotfi; Arvydas Maminishkis; Carl G Simon; Kapil Bharti
Journal:  J Ocul Pharmacol Ther       Date:  2016-04-25       Impact factor: 2.671

8.  Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue.

Authors:  Balendu Shekhar Jha; Kapil Bharti
Journal:  Curr Stem Cell Rep       Date:  2015-06

9.  Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer.

Authors:  Bruno Diniz; Padmaja Thomas; Biju Thomas; Ramiro Ribeiro; Yuntao Hu; Rodrigo Brant; Ashish Ahuja; Danhong Zhu; Laura Liu; Michael Koss; Mauricio Maia; Gerald Chader; David R Hinton; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-26       Impact factor: 4.799

10.  Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses.

Authors:  M Joseph Phillips; Kyle A Wallace; Sarah J Dickerson; Michael J Miller; Amelia D Verhoeven; Jessica M Martin; Lynda S Wright; Wei Shen; Elizabeth E Capowski; E Ferda Percin; Enio T Perez; Xiufeng Zhong; Maria V Canto-Soler; David M Gamm
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.